01.12.2015 • NewsElaine BurridgeKlesch GroupArkema

Court Dismisses Klesch Case Against Arkema

The International Chamber of Commerce Court of Arbitration has dismissed all claims by the Switzerland-based, US family-run Klesch Group against French chemical producer Arkema relating to the Klesch purchase of vinyls manufacturer Kem One in 2012.

In the ruling just handed down, the court ordered Klesch Chemicals to pay damages of €73.6 million to Arkema as well as reimbursing the majority of the French company’s costs.

As the opening scene of the protracted drama, the Klesch Group on Mar. 4, 2013 had accused Arkema of misrepresenting the financial position of its vinyls business and sought compensation of €310 million. Arkema, which said it was “deeply shocked” by the allegations, vowed to take all necessary steps to defend itself.

At the end of March 2013, Kem One filed for bankruptcy and at the beginning of 2014 was acquired by a consortium of Alain de Krassny, the 72-year-old supervisory board chairman of Austrian chemical producer Donau-Chemie, and US private equity group OpenGate Capital.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.